Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-23

Clinical Trial Update: Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT) [Phase 4]

View source ↗

Summary

Phase 4 NEwArT trial comparing nevirapine to atazanavir boosted with ritonavir on a Truvada background in HIV-infected, treatment-naive patients; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norvir (ritonavir)
  • REYATAZ (atazanavir)
  • TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
  • Viramune (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2011-05-23